Denali Therapeutics, Inc. (DNLI)
19.69
-0.68
(-3.34%)
USD |
NASDAQ |
Mar 05, 16:00
19.89
+0.20
(+1.02%)
After-Hours: 20:00
Denali Therapeutics Cash from Investing (TTM) : 255.28M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Protalix Biotherapeutics, Inc. | -16.57M |
| Enovis Corp. | -179.37M |
| Masimo Corp. | 275.10M |
| Twist Bioscience Corp. | -33.16M |
| Agenus, Inc. | 0.393M |